minicare acute, page-4

Seb.. i have had a gut feeling that November being when POC1 12mnth feasibility study ends and the expected acquisition to be completed is a too much of a coincidence.. We know ADO are ahead of schedule on this as well.. so who knows.. but either way if it was successful there will be a lump sum payment of monies as per their agreement or possibility a nice upfront.. so its a possibility imo..

Also .... Could ADO via Diasource become POC1's new full time assay developer (and manufacturer of some components at a stretch) moving forward ??? Being close neighbors it makes perfect sense.. so many options.. now wouldn't that in turn indirectly boost the Diasource reputation around the world ?.. swings and roundabouts and looking outside the box.. ADO seems to potentially bring a lot to the Diasource table that possibility is not initially apparent on the surface...